Commentaires de nos clients
Votre panier
€ 0.00 (0 articles)
Search:
Perform search
Liste des catégories

Générique Ropinirole - Requip

News
Recherche par lettre:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Requip
Requip Générique est utilisé pour traiter la maladie de Parkinson et le syndrome des jambes sans repos (SJSR).
€ 0.52
Bookmarks sociaux
Pays, langue et monnaie


Remboursementgaranti
Achatsécurisé

Notre page de facturation est certifiée par:

Secure shopping certificates

Special Offer!

  • Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended ... - MarketWatch (press release)

    Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended .

  • Actavis wins FDA approval for Ropinirole extended-release tablets - Pharmaceutical Business Review

    Actavis wins FDA approval for Ropinirole extended-release tabletsPharmaceutical Business ReviewActavis Group, a generic pharmaceuticals company, has gained FDA approval for Ropinirole extended-release tablets, 2mg, 4mg, 6mg, 8mg and 12mg.

  • Warner Chilcott sues Watson over Lo Loestrin; Actavis debuts generic Requip - The Pharma Letter

    Warner Chilcott sues Watson over Lo Loestrin; Actavis debuts generic RequipThe Pharma LetterSeparately, Switzerland headquartered Actavis Group, which is currently the subject of a 4.

  • NuPathe Announces First Quarter 2012 Financial Results and Operational Highlights - MarketWatch (press release)

    NuPathe Announces First Quarter 2012 Financial Results and Operational HighlightsMarketWatch (press release)NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery.

  • Safeguard Scientifics Announces First Quarter 2012 Financial Results - MarketWatch (press release)

    Safeguard Scientifics Announces First Quarter 2012 Financial ResultsMarketWatch (press release)NP201, for the continuous symptomatic treatment of Parkinson's disease, utilizes a leading FDA-approved dopamine agonist, ropinirole, and is being developed to provide up to two months of continuous delivery.

    Copyright © www.drugsengine.com is an affiliate marketing website. Tous droits réservés.